Search results
Order by most recent / most popular / relevance
Results: 1-9 of 9
Consent decree highlights antitrust risks for health insurers from exclusivity in provider network contracts
- Edwards Wildman Palmer LLP
- -
- USA
- -
- March 17 2011
On February 25, the United States Department of Justice filed a complaint against United Regional Health Care System, the dominant hospital in Wichita Falls, Texas, alleging an antitrust violation in its contracting practices with commercial health insurers
Repeal of antitrust exemption gains traction as House and Senate Democrats reconcile healthcare reform bills
- Edwards Wildman Palmer LLP
- -
- USA
- -
- January 8 2010
U.S. House Representatives Peter DeFazio, (D-OR) and Gene Taylor (D-MS) drafted a letter to House Speaker Nancy Pelosi (D-CA) in support of repealing the antitrust exemption under the McCarran Ferguson Act for health insurers and medical liability insurers
BCBS of MI antitrust case dropped
- Edwards Wildman Palmer LLP
- -
- USA
- -
- April 2 2013
On March 25, the U.S. Department of Justice (DOJ) and the State of Michigan agreed to dismiss an antitrust case against Blue Cross Blue Shield of
Legislation introduced to eliminate federal antitrust exemption for health insurance and medical malpractice insurance companies
- Edwards Wildman Palmer LLP
- -
- USA
- -
- September 17 2009
Today, Senate Judiciary Committee Chairman Patrick Leahy introduced legislation to eliminate the federal antitrust exemption for health insurance and medical malpractice insurance companies
House Committee votes to eliminate insurers’ federal antitrust exemption
- Edwards Wildman Palmer LLP
- -
- USA
- -
- October 22 2009
On October 21, the House Judiciary Committee voted to repeal health and medical malpractice insurers’ long-standing federal antitrust exemption
Health insurers’ motion to treble damages against pharmaceutical companies in antitrust case is granted
- Edwards Wildman Palmer LLP
- -
- USA
- -
- February 7 2008
On June 1, 2005, after a jury trial lasting over three weeks, a jury found for Blue Cross Blue Shield of Massachusetts (“BCBS-MA”), Blue Cross Blue Shield of Minnesota (“BCBS-MN”), Federated Mutual Insurance Company (“Federated”), and Health Care Service Corporation (“HCSC”) (collectively “Plaintiffs”) against Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc., Cambrex Corporation, and Gyma Laboratories (“Defendants”) on state law claims agreement in unreasonable restraint of trade; conspiracy in unreasonable restraint of trade; monopolization; and attempted monopolization in the Lorazepam active pharmaceutical ingredient (“API”) market, Lorazepam tablet market and in the Clorazepate API and tablet markets
New York radiology practice sues health care benefits administration firm contracted with major health care insurers alleging antitrust violations
- Edwards Wildman Palmer LLP
- -
- USA
- -
- June 27 2008
A New York based radiology practice (the “Plaintiff”) filed an action in the United States District Court for the Eastern District of New York against a benefits administration firm, CareCore National, LLC, that provides services for insurers including Aetna, GHI, HIP, Healthnet, Healthfirst, and Oxford
Partial repeal of the insurance antitrust exemption introduced as amendment to Senate healthcare bill
- Edwards Wildman Palmer LLP
- -
- USA
- -
- December 4 2009
Senator Patrick Leahy (D-VT) filed an amendment to the Patient Protection and Affordable Care Act (H.R. 3590) (the “PPACA”) on December 1, 2009, that would repeal the exemption from federal antitrust laws for the health insurance and medical malpractice insurance industries
House introduces health insurance bill to repeal antitrust exemption
- Edwards Wildman Palmer LLP
- -
- USA
- -
- February 24 2010
On Monday, February 22, Representatives Tom Perriello (D-Va.) and Betsy Markey (D-Colo.) introduced H.R. 4626, the Health Insurance Industry Fair Competition Act, to repeal the McCarran-Ferguson Act antitrust exemption for the business of health insurance
